Menu

GI & liver

8,202 trials in this section

Not yet recruiting NCT06484153

Fruquintinib and Pirfenidone in Combination With Anti-PD-1 Antibody in Advanced or Metastatic pMMR/MSS Colorectal Carcinoma

Phase I / Phase II Interventional

To Evaluate the Efficacy of Fruquintinib and Pirfenidone in Combination With Anti-PD-1 Antibody in Colorectal Carcinoma · To Evaluate Whether Pirfenidone Can Reshape the Tumor Microenvironment in Colorectal Cancer · Combination of Fruquintinib and Anti-PD-1 Antibody Was Reported to Improve Patient Prognosis in Colorectal Cancer